Skip to main content

1 Result(s)

within Cécile Juzot Remove this filter

and

  1. No Access

    Article

    Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma

    Vismodegib is indicated for the treatment of advanced or metastatic basal cell carcinoma (BCC). The predictive factors of response to vismodegib have so far been poorly described.

    Cécile Juzot, Anne Isvy-Joubert, Amir Khammari… in European Journal of Dermatology (2022)